Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for Venous Dysfunction in VTE Patients
NCT03988101Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Sep 2019
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of rosuvastatin in chronic venous insufficiency (CVI) (2 arms), sponsored by Yonsei University. Primary endpoint: Improvement of venous insufficiency at 6 months. Started Sep 2019; status: completed.
02
Drugs
rosuvastatin
03
Conditions
chronic venous insufficiency (CVI)
Beyond the preview
Go deeper on NCT03988101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03988101.